相关实验视频

Updated: Jan 15, 2026

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients

Published on: February 28, 2018

节律失调性心肌病和生物标志物:一个有希望的前景?

Federico Barocelli¹, Nicolò Pasini¹, Alberto Bettella¹

¹Cardiology Division, Parma University Hospital, 43126 Parma, Italy.

Journal of clinical medicine

|October 16, 2025

概括

生物标志物在诊断心律失常性心肌病 (ACM),一种心肌疾病方面表现有前途. 将这些标记物与成像和遗传学相结合,可以改善早期检测和个性化治疗.

科学领域:

心脏病学心脏病学
遗传学是一个遗传学.
生物标志物发现发现

背景情况:

节律失调性心肌病 (ACM) 是一种遗传性心肌疾病,导致心肌纤维化,心律失常和心脏突然死亡.
早期的ACM诊断是困难的,因为不完整的透率和可变的表达性,致命事件往往发生在早期.
需要可靠的生物标志物来提高诊断准确性,风险分层和ACM的临床管理.

研究的目的:

审查目前和新兴的心律失调性心肌病 (ACM) 的生物标志物.
评估生物标志物在加强ACM诊断和管理方面的潜在作用.
探索生物标志物与其他诊断方式的整合.

主要方法:

关于ACM生物标志物的科学文献叙述性综述.
检查各种生物标记物类别:热波宁,尿酸,炎症蛋白,微RNA,纤维化标记物.
在ACM诊断中讨论基因检测和心脏成像.

主要成果:

几种生物标志物与ACM严重程度,心律失常负担和疾病进展有关.
目前的生物标志物作为独立的诊断工具在常规临床实用性有限.
结合生物标志物,成像和遗传学的多式诊断策略显示出有希望.

结论:

没有单一的生物标志物足以进行独立的ACM诊断.
在多标记面板和新目标中进行的持续研究提供了未来的潜力.
将循环生物标志物与成像,遗传和临床数据相结合,可以改善早期ACM检测和个性化治疗.

关键词:

节律失常性心肌病变性心脏病变症生物标志物生物标志物早期诊断早期诊断早期诊断这是一个小RNARNA.突然的心脏病死亡.腹腔心律失常症腹腔心律失常症

更多相关视频

Measurement of Antibody Effects on Cellular Function of Isolated Cardiomyocytes

Measurement of Antibody Effects on Cellular Function of Isolated Cardiomyocytes

Published on: March 8, 2013

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Published on: December 22, 2023

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...

Cardiomyopathy IV: Restrictive Cardiomyopathy

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...